Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy-Reference-Cited by-同舟云学术

Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy

Published:2012-05-28 Issue:12 Volume:38 Page:1367-1375
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:

Author:

Kunito Shiro,Takakura Satoshi,Nagata Chie,Saito Motoaki,Yanaihara Nozomu,Yamada Kyosuke,Okamoto Aikou,Sasaki Hiroshi,Ochiai Kazunori,Tanaka Tadao

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1447-0756.2012.01884.x/fullpdf

Reference18 articles.

1. Annual report on Gynecologic Oncology Committee (2009);Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology;Acta Obstet Gynecol Jpn,2011

2. Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010;Anglesio;Gynecol Oncol,2011

3. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

4. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease;Goff;Gynecol Oncol,1996

5. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging;Rubin;Obstet Gynecol,1993

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages;Journal of Ovarian Research;2023-05-11

2. Recurrent ovarian clear cell carcinoma: a retrospective evaluation of the efficacy and prognostic factors;EUR J GYNAECOL ONCOL;2018

3. Impact of Surgical Staging in Stage I Clear Cell Adenocarcinoma of the Ovary;International Journal of Gynecologic Cancer;2014-09